skip to main content

H.R. 1273 (117th): Vietnam Veterans Liver Fluke Cancer Study Act


The text of the bill below is as of Feb 23, 2021 (Introduced). The bill was not enacted into law.


I

117th CONGRESS

1st Session

H. R. 1273

IN THE HOUSE OF REPRESENTATIVES

February 23, 2021

(for himself, Mr. Garbarino, Mr. Suozzi, Mr. Fitzpatrick, Mr. Posey, and Mr. Neguse) introduced the following bill; which was referred to the Committee on Veterans' Affairs

A BILL

To direct the Secretary of Veterans Affairs to study and report on the prevalence of cholangiocarcinoma in veterans who served in the Vietnam theater of operations during the Vietnam era, and for other purposes.

1.

Short title

This Act may be cited as the Vietnam Veterans Liver Fluke Cancer Study Act.

2.

Study on the prevalence of cholangiocarcinoma in veterans who served in the Vietnam theater of operations during the Vietnam era

(a)

Epidemiological study

Not later than 120 days after the date of enactment of this Act, the Secretary of Veterans Affairs, in consultation with the Director of the Centers for Disease Control and Prevention of the Department of Health and Human Services, shall commence an epidemiological study on the prevalence of cholangiocarcinoma in covered veterans of the Vietnam era, using data from the Veterans Affairs Central Cancer Registry and the National Program of Cancer Registries. The study shall—

(1)

identify the rate of incidence of cholangiocarcinoma in covered veterans of the Vietnam era and in residents of the United States, from the beginning of the Vietnam era to the date of enactment of this Act; and

(2)

for each of the groups specified in paragraph (1), identify the percentage of individuals with cholangiocarcinoma by various demographic characteristics, including by age, gender, race, ethnicity, and the geographic location of the patient at the time of diagnosis.

(b)

Report to Congress

Not later than one year after the completion of the study under subsection (a), the Secretary shall submit to Congress a report containing—

(1)

the results of the study under subsection (a); and

(2)

recommendations for administrative or legislative actions required to address issues identified in the study under subsection (a).

(c)

Continued tracking of cholangiocarcinoma in covered veterans of the Vietnam era

The Secretary shall track the prevalence of cholangiocarcinoma in covered veterans of the Vietnam era using the Veterans Affairs Central Cancer Registry, and provide such information to Congress as required under subsection (d).

(d)

Follow-Up reports

The Secretary shall periodically submit to the Congress an updated report under subsection (b), as determined by the Secretary.

(e)

Definitions

In this section:

(1)

The term Secretary means the Secretary of Veterans Affairs.

(2)

The term Vietnam era has the meaning given such term in section 101 of title 38, United States Code.

(3)

The term covered veterans of the Vietnam era means veterans who served in the Vietnam theater of operations during the Vietnam era.